chr12-50453610-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052879.5(LARP4):c.955G>A(p.Val319Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000793 in 1,613,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_052879.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LARP4 | NM_052879.5 | c.955G>A | p.Val319Ile | missense_variant | 9/16 | ENST00000398473.7 | NP_443111.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LARP4 | ENST00000398473.7 | c.955G>A | p.Val319Ile | missense_variant | 9/16 | 1 | NM_052879.5 | ENSP00000381490.2 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 152012Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000108 AC: 27AN: 249504Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135364
GnomAD4 exome AF: 0.0000801 AC: 117AN: 1461256Hom.: 0 Cov.: 30 AF XY: 0.0000770 AC XY: 56AN XY: 726948
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152130Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2024 | The c.955G>A (p.V319I) alteration is located in exon 9 (coding exon 9) of the LARP4 gene. This alteration results from a G to A substitution at nucleotide position 955, causing the valine (V) at amino acid position 319 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at